NEW YORK (GenomeWeb) — GreenLight Biosciences announced today that it has raised $50 million in an oversubscribed private financing round.

The round was led by S2G Ventures, Baird Capital, and Blue I/O. Other investors included Continental Grain Company, Tao Capital Partners, and Alexandria Venture Investments.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Germany's Project DEAL has come to an agreement with the publisher Wiley over journal access and open-access publishing, ScienceInsider reports.

Researchers uncover additional loci associated with lifespan, which the Telegraph says could be folded into a genetic test.

A Canadian panel recommends public coverage of the gene therapy Kymriah if its cost comes down, the Globe and Mail reports.

In Nucleic Acids Research this week: new accurate quantification by sequencing approach, CNV breakpoints in Plasmodium falciparum, and more.